Starting with our lead asset, avexitide, an investigational GLP-1 receptor antagonist with ... hypoglycemia following bariatric surgery in any form and any frequency it's as high as 30%, 40% ...

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs form part of their treatment, new research being presented at ...

This comprehensive review explores MEDVi, a leading telehealth provider offering compounded GLP-1 weight loss solutions like Semaglutide and Tirzepatide in both injection and tablet form.

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

outcomes in patients with type 2 diabetes treated with tirzepatide compared to GLP-1RAs like semaglutide. STEMI is a severe form of heart attack caused by the complete blockage of an artery ...

As consumers are clamoring for access to pricey GLP-1 drugs for weight loss, employers are feeling the need to modify or update their plans to accommodate new demands and costs. KFF's 2024 Employer ...

The observational, real-life retrospective cohort study found that in adults with obesity and type 2 diabetes but no prior heart disease, glucagon-like peptide-1 receptor agonists (GLP-1RAs ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He ...

The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later ...